Madrigal Pharmaceuticals, Inc. MDGL Business Segments
| FY'25 | ||
|---|---|---|
| Gross To Net Adjustments Reserve by Product | ||
| Chargebacks, Discounts for Prompt Pay and Other Allowances | $23.68M— | |
| Provision related to sales in the current year by Product | ||
| Chargebacks, Discounts for Prompt Pay and Other Allowances | $36.64M+355% | |
| Gross To Net Adjustments Reserve Credits And Payments Made by Product | ||
| Chargebacks, Discounts for Prompt Pay and Other Allowances | $30.42M+689% | |
| Adjustments related to prior year sales by Product | ||
| Chargebacks, Discounts for Prompt Pay and Other Allowances | -$1.57M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Madrigal Pharmaceuticals, Inc. break its business down?
- Madrigal Pharmaceuticals, Inc. (MDGL) reports gross to net adjustments reserve by product across 2 parts — Chargebacks, Discounts for Prompt Pay and Other Allowances and Rebates, Co-Pay Assistance, Returns, and Other. Each is extracted from the segment footnotes and tracked over time.
- Where does Madrigal Pharmaceuticals, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Madrigal Pharmaceuticals, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
